J. R. Stewart

发表

Prospects for Targeting Protein Kinase C Isozymes in the Therapy of Drug-resistant Cancer – An Evolving Story

N. Ward, C. O'Brian, J. Stewart, 2004, Cancer and Metastasis Reviews.

Resveratrol Antagonizes EGFR-Dependent Erk1/2 Activation in Human Androgen-Independent Prostate Cancer Cells with Associated Isozyme-Selective PKCα Inhibition

C. O'Brian, J. Stewart, C. O'brian, 2004, Investigational New Drugs.

Resveratrol: a candidate nutritional substance for prostate cancer prevention.

C. O'Brian, J. Stewart, Marlene C. Artime, 2003, The Journal of nutrition.

Protein kinase C-α mediates epidermal growth factor receptor transactivation in human prostate cancer cells

Jubilee R. Stewart, Catherine A. O'Brian, C. O'Brian, 2005, Molecular Cancer Therapeutics.

Effects of resveratrol on the autophosphorylation of phorbol ester-responsive protein kinases: inhibition of protein kinase D but not protein kinase C isozyme autophosphorylation.

K. Christman, C. O'Brian, J. Stewart, 2000, Biochemical pharmacology.

Protein kinase CA mediates epidermal growth factor receptor transactivation in human prostate cancer cells

C. O'Brian, J. Stewart, C. O'brian, 2005 .

Irreversible inactivation of protein kinase C isozymes by thiol-reactive peptide substrate analogs.

N. Ward, C. O'Brian, J. Stewart, 2003, Methods in molecular biology.

Cancer Chemoprotective Activity of Stilbenes: Resveratrol

C. O'Brian, J. Stewart, F. Chu, 2005 .

Protein kinase C-{alpha} mediates epidermal growth factor receptor transactivation in human prostate cancer cells.

C. O'Brian, Jubilee R Stewart, Catherine A O'Brian, 2005, Molecular cancer therapeutics.